European oil giant Royal Dutch Shell has appointed a new head of IR, as its current chief Tjerk Huysinga departs after 35 years at the company.
Mohammed Hamid will take over as Shell’s head of investor relations and strategic planning from June 1, the company says. Veteran oil and gas analyst Oswald Clint will also join the team later this year after 20 years at AP Bernstein.
Meanwhile, New York-listed American Healthcare REIT has announced that Alan Peterson has joined the company as vice president of investor relations and finance. He now leads the medical property-focused real estate investment trust’s (Reit) investor relations efforts and various strategic initiatives, the company says.
Peterson was previously an equity research analyst on the residential research team at Green Street, a commercial real estate-focused research and advisory firm.
‘Alan is a key addition to our team and plays an important role in our new chapter as an NYSE-listed company,’ says Danny Prosky, CEO and president of American Healthcare REIT. ‘He is a bright young executive with an exceptional professional background and a keen understanding of the publicly traded Reit industry who we are very pleased to have join our team at this important point in our history.’
Fellow NYSE-listed firm OPENLANE, an operator of digital marketplaces for wholesale used vehicles, has announced that its head of IR and treasurer Mike Eliason will retire from his role after more than 25 years at the firm.
Eliason will continue to serve in his position at the company, which made its stock market debut earlier this month, until a successor is named, while Brad Lakhia, executive vice president and CFO, will assume the role of treasurer.
‘Mike has been a valued member of the OPENLANE team for 25 years and has led our investor relations program for the last seven, playing a key role in communicating about our company’s growth and transformation to our customers, business partners and stockholders,’ says Lakhia. ‘I want to thank Mike for his leadership and congratulate him on his well-deserved retirement.’
Finally, Nasdaq-listed biopharmaceutical company InflaRx has appointed Jan Medina as its new head of investor relations.
Medina previously served at Olink Proteomics where he was vice president of investor relations & capital markets, and previously served on the buy side and sell side.
Prof Niels Riedemann, CEO and founder of InflaRx, says: ‘We are delighted to welcome Jan to our team. His experience, proven track record and deep network with investors and capital markets will be invaluable as we continue to advance our clinical programs and strengthen our relationships with the investor community.’
Medina adds: ‘It’s a privilege to join InflaRx during this exciting time, with its strong execution and as the company broadens its development efforts to meaningfully improve the treatment of chronic immune-inflammatory diseases.’
Laurie Havelock
Laurie has been part of the IR Magazine team for more than a decade, starting out as a reporter and research editor before becoming editor in 2023. He was previously acting business editor at the i newspaper and deputy business editor at The Daily...
